Shujun Li, MS

Budget Impact Analysis of Esketamine Nasal Spray in a Sub-Population of Adults With Major Depressive Disorder and High Unmet Need: Payer Perspective in the United States

Background: Esketamine nasal spray (ESK) plus comprehensive standard of care (SOC) vs placebo plus SOC was studied in two phase 3 antidepressant clinical trials among a sub-population of ...

Hoa Le , PhD;

Hector Toro-Diaz , PhD;

Shujun Li , MS;

John J. Sheehan , PhD, MBA, RPh;

Jennifer Voelker , MS, PharmD;

10/08/2020

Modeling the Natural Course of Treatment-Resistant Depression Using the US STAR*D Data

Predictive equations were derived to characterize the natural course of treatment-resistant depression (TRD). Patients experiencing major depressive disorder symptoms after failing two an...

Qiaoyi Zhang , MD, PhD;

Hoa Le , PhD;

Hector Toro-Diaz , PhD;

Shujun Li , MS;

Luis Hernandez , MSc;

Shien Guo , PhD;

Arman Altincatal , MS;

Josh Weng , MS;

03/01/2019